{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:44:47Z","timestamp":1781786687694,"version":"3.54.5"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["tuberculosisjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.tube.2016.02.003","type":"journal-article","created":{"date-parts":[[2016,2,26]],"date-time":"2016-02-26T07:47:21Z","timestamp":1456472841000},"page":"27-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"98","author":[{"given":"Silvan","family":"Vesenbeckh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Krieger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gudrun","family":"Bettermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sch\u00f6nfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten Thomas","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"R\u00fcssmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2016.02.003_bib1","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1183\/09031936.00113713","article-title":"Potential antimicrobial agents for the treatment of multidrug-resistant tuberculosis","volume":"43","author":"Alsaad","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/j.tube.2016.02.003_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S1473-3099(14)70006-4","article-title":"Improving the health of the tuberculosis drug pipeline","volume":"14","author":"Burki","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.tube.2016.02.003_bib3","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1517\/13543784.2011.628657","article-title":"Phenothiazines as anti-tubercular agents: mechanistic insights and clinical implications","volume":"20","author":"Sharma","year":"2011","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.tube.2016.02.003_bib4","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1159\/000239036","article-title":"Chlorpromazine: a drug potentially useful for treating mycobacterial infections","volume":"38","author":"Crowle","year":"1992","journal-title":"Chemotherapy"},{"key":"10.1016\/j.tube.2016.02.003_bib5","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1128\/AAC.47.3.917-922.2003","article-title":"Clinical concentrations of thioridazine kill intracellular multidrug-resistant Mycobacterium tuberculosis","volume":"47","author":"Ordway","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.tube.2016.02.003_bib6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0009-9236(96)90150-2","article-title":"Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans","volume":"60","author":"Hartigan-Go","year":"1996","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.tube.2016.02.003_bib7","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1520\/JFS14405J","article-title":"Redistribution of basic drugs into cardiac blood from surrounding tissues during early-stages postmortem","volume":"44","author":"Moriya","year":"1999","journal-title":"J\u00a0forensic Sci"},{"key":"10.1016\/j.tube.2016.02.003_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012640","article-title":"The antipsychotic thioridazine shows promising therapeutic activity in a mouse model of multidrug-resistant tuberculosis","volume":"5","author":"van Soolingen","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.02.003_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijantimicag.2009.12.019","article-title":"Thioridazine cures extensively drug-resistant tuberculosis (XDR-TB) and the need for global trials is now!","volume":"35","author":"Amaral","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2016.02.003_bib10","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/jac\/dkr500","article-title":"Successful alternative treatment of extensively drug-resistant tuberculosis in Argentina with a combination of linezolid, moxifloxacin and thioridazine","volume":"67","author":"Abbate","year":"2012","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.tube.2016.02.003_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.4103\/0970-2113.102794","article-title":"Minimal inhibitory concentrations of first-line drugs of multidrug-resistant tuberculosis isolates","volume":"29","author":"Schonfeld","year":"2012","journal-title":"Lung India"},{"key":"10.1016\/j.tube.2016.02.003_bib12","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijantimicag.2006.10.013","article-title":"In\u00a0vitro and ex\u00a0vivo activity of thioridazine derivatives against Mycobacterium tuberculosis","volume":"29","author":"Martins","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2016.02.003_bib13","doi-asserted-by":"crossref","first-page":"e44245","DOI":"10.1371\/journal.pone.0044245","article-title":"Activity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosis","volume":"7","author":"Advani","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2016.02.003_bib14","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0924-8579(00)00343-5","article-title":"Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines","volume":"17","author":"Viveiros","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tube.2016.02.003_bib15","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.tube.2014.08.016","article-title":"Chemotherapeutic efficacy of thioridazine as an adjunct drug in a murine model of latent tuberculosis","volume":"94","author":"Singh","year":"2014","journal-title":"Tuberculosis"},{"key":"10.1016\/j.tube.2016.02.003_bib16","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1176\/appi.ajp.158.11.1774","article-title":"Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death","volume":"158","author":"Glassman","year":"2001","journal-title":"Am J psychiatry"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1472979215302924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T21:53:24Z","timestamp":1536962004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1472979215302924"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":16,"alternative-id":["S1472979215302924"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2016.02.003","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroleptic drugs in the treatment of tuberculosis: Minimal inhibitory concentrations of different phenothiazines against Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2016.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}